378 results match your criteria: "Jikei University Hospital.[Affiliation]"
Lancet
January 2025
Division of Transfusion Medicine and Cell Therapy, The Jikei University Hospital, Tokyo 105-8471, Japan. Electronic address:
J Hum Genet
January 2025
Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan.
Large-scale population cohort studies that collect genomic information are tasked with returning an assessment of genetic risk for hereditary cancers to participants. While several studies have applied to return identified genetic risks to participants, comprehensive surveys of participants' understanding, feelings, and behaviors toward cancer risk remain to be conducted. Here, we report our experience and surveys of returning genetic risks to 100 carriers of pathogenic variants for hereditary cancers identified through whole genome sequencing of 50 000 individuals from the Tohoku Medical Megabank project, a population cohort study.
View Article and Find Full Text PDFBurns Trauma
January 2025
Australian and New Zealand Intensive Care-Research Centre, Monash University School of Public Health and Preventive Medicine, 553 St Kilda Road, Melbourne VIC 3004, Australia.
Septic shock is a significant challenge in the management of patients with burns and traumatic injuries when complicated by infection, necessitating prompt and effective haemodynamic support. This review provides a comprehensive overview of current strategies for vasopressor and fluid management in septic shock, with the aim to optimize patient outcomes. With regard to vasopressor management, we elaborate on the pharmacologic profiles and clinical applications of catecholamines, vasopressin derivatives, angiotensin II, and other vasoactive agents.
View Article and Find Full Text PDFNurs Open
January 2025
The Jikei University School of Nursing, Tokyo, Japan.
Aim: (1) To classify patients with community-acquired pressure injury (CAPI) according to the risk factors of PI and to assess validity of the classified groups. (2) To clarify characteristics of each group for CAPI prevention and care.
Design: This study is designed to classify CAPI patients into clusters based on a retrospective study of medical records, followed by cluster analysis and description of each cluster's characteristics.
Crit Care
December 2024
Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Background: Excessive exposure to adrenergic vasopressors may be harmful. Non-adrenergic vasopressors may spare adrenergic agents and potentially improve outcomes. We aimed to conduct a systematic review and meta-analysis of randomized controlled trials (RCTs) to evaluate the efficacy of non-adrenergic vasopressors in adult patients receiving vasopressor therapy for vasodilatory shock or perioperative vasoplegia.
View Article and Find Full Text PDFIntern Med
December 2024
Department of Respiratory Medicine, Saitama Red Cross Hospital, Japan.
Acta Anaesthesiol Scand
January 2025
Department of Intensive Care, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Int J Hematol
January 2025
Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-0003, Japan.
Purpose: To determine the current incidence and impact of chemotherapy-associated food aversions in a variety of cancer types.
Methods: Cancer patients aged 18 years and older who received chemotherapy infusions at the outpatient chemotherapy unit of a university hospital between May 2022 and April 2023 were included in the study (n = 243). To monitor the occurrence of food aversions, participants were asked to complete a food preference questionnaire each time they visited the outpatient chemotherapy unit.
J Anus Rectum Colon
October 2024
Department of Surgery, The Jikei University Hospital, Tokyo, Japan.
J Crit Care
February 2025
Faculty of Medicine, University of Queensland, Mayne Medical School, 20 Weightman St, Brisbane, QLD 4006, Australia; Queensland University of Technology (QUT), 2 George St, Brisbane, QLD 4000, Australia; Intensive Care Unit, Princess Alexandra Hospital, 199 Ipswich Rd, Woolloongabba, QLD 4102, Australia. Electronic address:
Purpose: Clinical trials focusing on critically ill patients with metabolic acidosis, a common exclusion criterion is the presence of a PaCO > 45 mmHg. The aim of this study was to assess the impact of mild hypercapnia on patient characteristics, severity, and clinical outcomes in critically ill patients with metabolic acidosis.
Material And Methods: Multicentre, retrospective, observational study conducted in 12 intensive care units (ICUs) in Queensland, Australia.
Int J Clin Oncol
December 2024
Department of Urology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Int J Clin Oncol
December 2024
Department of Urology, Kindai University Hospital, Osaka, Japan.
Background: Upfront androgen receptor signaling inhibitor (ARSI) along with androgen deprivation therapy is the current standard of care for metastatic castration-sensitive prostate cancer. However, evidence on second-line therapy after upfront ARSI is scarce. We aimed to evaluate the oncological outcome of ARSI versus docetaxel (DOC) after upfront ARSI therapy in a real-world clinical practice.
View Article and Find Full Text PDFBackground: In a randomized phase II/III trial (JCOG1008), weekly cisplatin (40 mg/m) was non-inferior to 3-weekly cisplatin (100 mg/m) for postoperative high-risk head and neck cancer. We investigated how acute kidney injury (AKI), a major dose-limiting toxicity effect of cisplatin, affects overall survival (OS).
Methods: We analyzed 251 patients from JCOG1008 receiving chemoradiotherapy.
J Clin Epidemiol
December 2024
Departments of Health Promotion and Human Behavior and of Clinical Epidemiology, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan.
Acta Anaesthesiol Scand
October 2024
Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Introduction: Use of albumin is suggested for some patients with shock, but preferences for its use may vary among intensive care unit (ICU) physicians.
Methods: We conducted an international online survey of ICU physicians with 20 questions about their use of albumin and their opinion towards a randomised trial among adults with shock comparing the use versus no use of albumin.
Results: A total of 1248 respondents participated, with a mean response rate of 37%, ranging from 18% to 75% across 21 countries.
Int J Urol
December 2024
Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Ann Surg
September 2024
Department of Colorectal Surgery, National Cancer Center Hospital East.
Objective: This study aimed to understand the effectiveness of regular care in reducing the incidence of severe peristomal skin disorders, as well as to identify their risk factors.
Summary Background Data: Peristomal skin disorders occur frequently in outpatient settings and require appropriate intervention. It remains, however, to be demonstrated when the need to follow up these patients decreases and whether assessing severity of peristomal skin disorders is useful.
Cureus
August 2024
Department of Public Health and Environmental Medicine, Jikei University School of Medicine, Tokyo, JPN.
Background This study aimed to evaluate the quality of life (QOL) of older adults using cochlear implants (CIs) by focusing on how individual characteristics and speech perception are related to generic QOL ratings and utilizing the Health Utilities Index Mark III (HUI3) for assessment. Methodology A cross-sectional study was conducted with 19 participants aged ≥60 years, who were within one to five years post-implant activation. Data were obtained through self-administered questionnaires, including the HUI3 for generic QOL assessment and disease-specific indexes.
View Article and Find Full Text PDFJpn J Clin Oncol
October 2024
Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Background: Over the last decade, novel anticancer drugs have improved the prognosis for recurrent or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN). However, this has increased healthcare expenditures and placed a heavy burden on patients and society. This study investigated the frequency of use and costs of select palliative chemotherapy regimens in Japan.
View Article and Find Full Text PDFCureus
July 2024
Department of Neurology, The Jikei University Katsushika Medical Center, Tokyo, JPN.
Anti-amphiphysin antibody is a rare paraneoplastic autoantibody. A case of a 74-year-old man with anti-amphiphysin antibody and multiple symptoms, including bulbar palsy along with cerebellar ataxia, who responded to treatment with intravenous cyclophosphamide is reported. The patient presented with progressive unsteady gait and difficulty in swallowing food and water for three months.
View Article and Find Full Text PDFJ Clin Neuromuscul Dis
September 2024
Department of Neurology, Teikyo University School of Medicine, Tokyo, Japan.
Objectives: To document the utility of decremental responses in the repetitive nerve stimulation test (RNS) and spontaneous activities in needle electromyography (EMG) in the trapezius muscle for the diagnosis of amyotrophic lateral sclerosis.
Methods: Subjects were retrospectively identified from our EMG database. Cervical spondylosis was represented as a disease control group.
Crit Care Resusc
June 2024
School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Importance: Cervical cancer is a common and lethal cancer worldwide. Bintrafusp alfa is a first-in-class bifunctional fusion protein composed of the extracellular domain of the human transforming growth factor β receptor II (or transforming growth factor β trap) fused via a flexible linker to the C-terminus of each heavy chain of an immunoglobulin G1 antibody blocking programmed cell death 1 ligand 1.
Objective: To evaluate the safety and response rates of bintrafusp alfa in patients with recurrent or metastatic cervical cancer.
Clin Respir J
July 2024
Department of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, Japan.
Background: Although transbronchial lung cryobiopsy (TBLC) is widely used in diagnostic algorithms for various interstitial lung diseases (ILDs), its real-world utility in the therapeutic decision-making strategy for ILD patients remains unclear, in particular, when judging the time to start antifibrotic agents.
Methods: We analyzed medical records of 40 consecutive patients with idiopathic or fibrotic hypersensitivity pneumonitis who underwent TBLC. A TBLC-based usual interstitial pneumonia (UIP) score was used to assess three morphologic descriptors: patchy fibrosis, fibroblastic foci, and honeycombing.